# Sysmex Inostics

supplies PlasmaSeqSensei NGS kits and targeted panel assays for oncology, with published clinical evidence (JAMA Oncology) that its circulating-tumor-HPV-DNA (HPV-Seq) assay predicts improved survival when used to monitor treatment clearance.

Source: https://en.bioecon.ru/companies/sysmex-inostics/
Updated: 2026-07-20

- Country: Germany

## Technologies

- [Liquid biopsy & ctDNA diagnostics](https://en.bioecon.ru/technology/liquid-biopsy-ctdna-diagnostics/)